Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy

ClinicalTrials.gov ID: NCT04620369

Public ClinicalTrials.gov record NCT04620369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Rose Geranium in Sesame Oil Nasal Spray as an Agent to Improve Symptoms of Nasal Vestibulitis: A Phase III Double Blinded Randomized Controlled Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase III trial compares rose geranium in sesame oil nasal spray to isotonic nasal saline in improving symptoms of nasal vestibulitis in cancer patients receiving chemotherapy. Nasal (nose) symptoms (dryness, discomfort, bleeding, scabbing or sores) due to inflammation, termed nasal vestibulitis, is reported as a side effect of cancer-directed therapy. Rose geranium in sesame oil nasal spray may work better than isotonic nasal saline in improving symptoms of nasal vestibulitis.

Study identification

NCT ID
NCT04620369
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mayo Clinic
Other
Enrollment
106 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 12, 2020
Primary completion
Dec 14, 2022
Completion
Dec 14, 2022
Last update posted
Dec 2, 2025

2020 – 2022

United States locations

U.S. sites
20
U.S. states
1
U.S. cities
19
Facility City State ZIP Site status
Mayo Clinic Health System in Albert Lea Albert Lea Minnesota 56007
Essentia Health Saint Joseph's Medical Center Brainerd Minnesota 56401
Essentia Health - Deer River Clinic Deer River Minnesota 56636
Essentia Health Saint Mary's - Detroit Lakes Clinic Detroit Lakes Minnesota 56501
Essentia Health Cancer Center Duluth Minnesota 55805
Essentia Health Ely Clinic Ely Minnesota 55731
Essentia Health - Fosston Fosston Minnesota 56542
Fairview Grand Itasca Clinic & Hospital Grand Rapids Minnesota 55744
Essentia Health Hibbing Clinic Hibbing Minnesota 55746
Fairview Range Medical Center Hibbing Minnesota 55746
Essentia Health - International Falls Clinic International Falls Minnesota 56649
Mayo Clinic Health Systems-Mankato Mankato Minnesota 56001
Monticello Cancer Center Monticello Minnesota 55362
Essentia Health - Park Rapids Park Rapids Minnesota 56470
Fairview Northland Medical Center Princeton Minnesota 55371
Mayo Clinic in Rochester Rochester Minnesota 55905
Essentia Health Sandstone Sandstone Minnesota 55072
Sanford Thief River Falls Medical Center Thief River Falls Minnesota 56701
Essentia Health Virginia Clinic Virginia Minnesota 55792
Sanford Cancer Center Worthington Worthington Minnesota 56187

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04620369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04620369 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →